Skip to main content

Akebia Therapeutics, Inc.

AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001517022

No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Akebia Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
114
+12 vs. Q2 2024
Shares held
59.4M
+14.8M (+33.1%) vs. Q2 2024
Total value
$78.4M
+$32.9M (+72.2%) vs. Q2 2024
New holders
27
31 more added
Sold out
15
25 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 114 institutions
Q1 2021: 145 institutionsQ2 2021: 139 institutionsQ3 2021: 127 institutionsQ4 2021: 133 institutionsQ1 2022: 124 institutionsQ2 2022: 97 institutionsQ3 2022: 90 institutionsQ4 2022: 75 institutionsQ1 2023: 65 institutionsQ2 2023: 79 institutionsQ3 2023: 76 institutionsQ4 2023: 87 institutionsQ1 2024: 114 institutionsQ2 2024: 103 institutionsQ3 2024: 114 institutionsQ4 2024: 121 institutionsQ1 2025: 143 institutionsQ2 2025: 158 institutionsQ3 2025: 177 institutionsQ4 2025: 166 institutionsQ1 2026: 171 institutionsQ2 2026: 170 institutions
Value heldQ3 2024: $78.4M
Q1 2021: $340.3MQ2 2021: $402.4MQ3 2021: $283.7MQ4 2021: $218.7MQ1 2022: $58.3MQ2 2022: $20.2MQ3 2022: $16.5MQ4 2022: $30.2MQ1 2023: $29.1MQ2 2023: $46.0MQ3 2023: $58.0MQ4 2023: $72.7MQ1 2024: $104.3MQ2 2024: $57.4MQ3 2024: $78.4MQ4 2024: $128.9MQ1 2025: $182.7MQ2 2025: $394.1MQ3 2025: $337.7MQ4 2025: $190.4MQ1 2026: $141.4MQ2 2026: $123.2M
Institutions holding AKBA and their total value by quarter
QuarterHoldersValue
Q2 2026170$123.2M
Q1 2026171$141.4M
Q4 2025166$190.4M
Q3 2025177$337.7M
Q2 2025158$394.1M
Q1 2025143$182.7M
Q4 2024121$128.9M
Q3 2024114$78.4M
Q2 2024103$57.4M
Q1 2024114$104.3M
Q4 202387$72.7M
Q3 202376$58.0M
Q2 202379$46.0M
Q1 202365$29.1M
Q4 202275$30.2M
Q3 202290$16.5M
Q2 202297$20.2M
Q1 2022124$58.3M
Q4 2021133$218.7M
Q3 2021127$283.7M
Q2 2021139$402.4M
Q1 2021145$340.3M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding AKBA in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Charles Schwab Investment Management Inc568,667$750.6K0.00%−2,307−0.4%Reduced
FMR LLC682,038$900.3K0.00%+140,529+26.0%Added
Federated Hermes, Inc.868,021$1.15M0.00%+2,769+0.3%Added
Connor, Clark & Lunn Investment Management Ltd.1,046,691$1.38M0.01%+632+0.1%Added
Morgan Stanley1,088,892$1.44M0.00%+325,560+42.6%Added
Qube Research & Technologies Ltd1,323,729$1.75M0.00%−420,887−24.1%Reduced
Northern Trust Corp1,635,099$2.16M0.00%+1,198,213+274.3%Added
Jacobs Levy Equity Management, Inc2,034,169$2.69M0.01%−60,564−2.9%Reduced
State Street Corp3,430,527$4.53M0.00%+683,287+24.9%Added
Renaissance Technologies LLC3,717,800$4.91M0.01%−197,000−5.0%Reduced
Geode Capital Management, LLC4,754,464$6.28M0.00%+218,172+4.8%Added
Satter Management Co., L.P.5,747,906$7.59M12.17%00.0%Unchanged
Vanguard Group Inc10,070,298$13.3M0.00%+794,035+8.6%Added
BlackRock, Inc.15,197,207$20.1M0.00%+15,197,207New
Acadian Asset Management LLC0$00.00%−4,063,383−100.0%Sold out
Marshall Wace, LLP0$00.00%−247,069−100.0%Sold out
Citadel Advisors LLC0$00.00%−214,669−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−211,647−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−129,896−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−57,624−100.0%Sold out
Marathon Trading Investment Management LLC0$00.00%−52,651−100.0%Sold out
Edmond de Rothschild Holding S.A.0$00.00%−50,000−100.0%Sold out
Envestnet Asset Management Inc0$00.00%−16,500−100.0%Sold out
Sykon Capital LLC0$00.00%−15,000−100.0%Sold out
Colony Group, LLC0$00.00%−10,575−100.0%Sold out
GWM Advisors LLC0$00.00%−2,535−100.0%Sold out
Redwood Wealth Management Group, LLC0$00.00%−300−100.0%Sold out
Laurel Wealth Advisors LLC0$00.00%−229−100.0%Sold out
Headlands Technologies LLC0$00.00%−208−100.0%Sold out
BlackRock Inc.––––Not filed